VAERS reports by lot

Janssen (J&J) COVID-19 lot 213021A: VAERS reports

37 VAERS reports list lot 213021A as a Janssen (J&J) COVID-19 vaccine, received between 2021-11-04 and 2024-01-27. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
37
Reports
16%
Marked serious
2
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)4829%
Gastrointestinal3018%
Neurological2918%
Cardiac / Cardiovascular2113%
Respiratory127%
Musculoskeletal85%
Allergic / Anaphylactic53%
Injection-site / Local reaction53%
Dermatological (non-injection-site)42%
Thrombotic / Hematological11%
Autoimmune / Immune-mediated11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan4
North Carolina3
California3
Virginia2
Georgia2
Missouri2
New York2
Utah1
Colorado1
Mississippi1
Pennsylvania1
South Carolina1

Reports by month received

2021-117
2021-1211
2022-012
2022-024
2022-031
2022-041
2022-062
2022-071
2022-082
2022-101
2022-113
2023-051
2024-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.